Hydroxamic acid derivative
AssigneeYamanouchi Pharmaceutical Co., Ltd.
InventorsYasuo Isomura, Seijiro Akamatsu, Toru Yoden, Masafumi Kudou, Akira Suga
Life of this patent
Estimating the term…
Abstract
The abstract isn’t available for this document.
Claims7
A compound represented by the following formula (I):
- ##STR31## each character in this formula means as follows;
- R.sup.1 :
- a lower alkyl group which may be substituted by a substituent group selected from the class consisting of a mercapto group, a lower alkylthio group, an arylthio group and a lower acylthio group,
- R.sup.2, R.sup.3 and R.sup.4 :
- the same or different from one another and each represents a lower alkyl group,
- X:
- an oxygen atom or a sulfur atom,
- Y:
- a single bond or a lower alkylene group, a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable hydrate thereof, a pharmaceutically acceptable solvate thereof or a stereoisomer thereof.
N.sup..alpha. -[[3-(N-hydroxycarbamoyl)-4-methylthio-2-propoxymethyl]butylyl]-N,O-dimeth yltyrosine amide, a pharmaceutically acceptable salt thereof or a stereoisomer thereof.
N.sup..alpha. -[[3-(N-hydroxycarbamoyl)-4-isopropylthio-2-propoxymethyl]butylyl]-N,O-dim ethyltyrosine amide, a pharmaceutically acceptable salt thereof or a stereoisomer thereof.
N.sup..alpha. -[[3-(N-hydroxycarbamoyl)-2-propylthio]butylyl]-N,O-dimethyltyrosine amide, a pharmaceutically acceptable salt thereof or a stereoisomer thereof.
Dependencies are inferred from the claim text.